SAMSUNG BIOLOGICS CO., LTD. 20/03/2026 AGM
1Approve Financial StatementsOppose
2.1Amend Articles: Exclusion of cumulative votingFor
2.2Amend Articles: Reflection of amendments to the Commercial ActFor
3.1Re-elect inside director John Rim - Chair (Executive)Oppose
3.2Re-elect Kun Lo - Executive DirectorOppose
4Elect Jung-Yeun Kim as an Independent Director and appoint to the Audit CommitteeFor
5Approve Fees Payable to the Board of DirectorsFor